NASDAQ · Biotechnology

XCUR (XCUR) Stock

$1.75 -0.57% NASDAQ: XCUR Healthcare

Valuation

MetricValue
Price$1.75
Market Cap$11.15M
P/E Ratio-3.53
P/B Ratio4.48
P/S Ratio0.00
EPS (TTM)$-0.79
52-Week High$9.50
52-Week Low$1.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-145.16%
ROA-32.51%
ROCE-250.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$29.0M$0$1.0M$0
Operating Profit$-63.0M$-2.0M$-15.0M$-12.0M$-10.0M
Net Profit$-64.0M$-3.0M$-17.0M$-10.0M$-5.0M
EPS$-21.70$-0.56$-2.11$-1.59$-0.79
Op Margin12950.1%-6.3%—-2446.4%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$65.0M$23.0M$12.0M$15.0M$14.0M
Total Liabilities$54.0M$8.0M$9.0M$8.0M$10.0M
Cash$35.0M$9.0M$1.0M$13.0M$4.0M
Borrowings$15.0M$7.0M$7.0M$6.0M$0

Latest News

Exicure Announces Board and Committee Changes GlobeNewswire · Jun 30, 2026 Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement GlobeNewswire · Jun 10, 2026 Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-36.0M$-10.0M$-3.0M$-9.0M
Investing Cash Flow$42.0M$5.0M$-1.0M$0$-2.0M
Financing Cash Flow$0$-1.0M$-2.0M$0$0
Net Cash Flow$9.0M$-34.0M$-8.0M$10.0M$-9.0M
Free Cash Flow$-36.0M$-36.0M$-10.0M$-3.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-1.79
FCF Yield-45.55%
Quick Ratio0.79
Interest Coverage—
Return 1Y-76.35%
Return 3Y-76.18%
Return 5Y-99.23%

Ownership

Insiders Held42.59%
Institutions Held2.69%
Institutions Float Held4.69%
Institutional HolderSharesReport Date
Carlyle Group Inc.56,3282026-03-31
Geode Capital Management, LLC36,9132026-03-31
Vanguard Capital Management LLC32,9832026-03-31
Vanguard Fiduciary Trust Co13,1612026-03-31
Northern Trust Corporation10,6862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLGN $0.27 -9.04% -0.48 $3.54M 0.00%
CVKD $2.06 +0.98% -0.78 $6.38M 0.00%
IBIO $1.45 +1.40% -0.91 $22.89M 0.00%
KLTOKlotho Neurosciences, Inc. $0.38 -7.10% -1.13 $20.08M 0.00%
MTVA $1.42 -1.39% -0.16 $3.13M 0.00%

About XCUR

XCUR is led by CEO Jungsoo Kim, employs 7 people, headquartered in US, publicly traded since 2018.

XCUR stock trades at $1.75 with a market capitalization of $11.15M. The stock is valued at a price-to-earnings (P/E) ratio of -3.53, price-to-book of 4.48, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.45 and $9.50, and currently trades 81.6% below its 52-week high.

On profitability, XCUR generates a return on equity (ROE) of -145.16%, return on capital employed of -250.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides